The Global Fund to Fight AIDS, Tuberculosis and Malaria

India

Expansion of the revised national tuberculosis control program to the "uncovered' 110 million population of Bihar and Uttar Pradesh and strengthening of DOTS in four urban areas

Principal Recipient

Department of Economic Affairs, Ministry of Finance of India

Grant Summary

TB is one of the deadliest and most devastating health burdens India has known over the past decades. Globally, India ranks first in terms of absolute numbers of cases. But TB incidence is now estimated to be declining. The main objectives of the program supported by this grant are to expand the Revised National TB Control Program to the “uncovered” population; to achieve at least 85 percent success in treatment amongst registered new smear-positive pulmonary TB cases; and to establish model urban TB control projects in four major cities to improve the quality and reach of the Revised National TB Control Program to vulnerable populations. In view of strong program performance and demonstrated potential for impact, the grant activities are being scaled up throughout the country under additional funding approved in 2009. The grant was consolidated with IDA-405-G08-T and IDA-607-G09-T.

Program Areas

Treatment
Timely detection and quality treatment of cases

Prevention
Identification of Infectious Cases
Behavioral Change Communication - Community Outreach

Supportive Environment
Coordination and partnership development (national, community, public-private)

Other
High Quality DOTS.
All care providers (PPM / ISTC - Public-Public, Public-Private Mix (PPM) approaches and International standards for TB care)
MDR-TB
TB/HIV
Improving diagnosis
Procurement and Supply management

Grant performance snapshot
A1
A2
B1
B2
C

Grants are measured and rated against country-owned targets at each periodic disbursement of funds (every 3, 6 or 12 months). The grants are rated according to the table below:

A1

A1 - Exceeds expectations

A2

A2 - Meets expectations

B1

B1 - Adequate

B2

B2 - Inadequate but potential demonstrated

C

C - Unacceptable

Financial overview

Total signed amount

US$ 107,685,429

Total disbursement

US$ 85,704,608

Expenditure

77.00 %

Grant overview
  • Grant number

    IDA-202-G03-T-00

  • Disease and Round

    Tuberculosis- 2

  • Duration

    01 April 2004 - 31 March 2012

  • Last disbursement

    24 November 2011

  • Phase and Status

    RCC I - In Progress

Grant amounts
  • Total signed amount

    US$ 107,685,429

  • Phase I

    US$ 7,572,870

  • Phase II

    US$ 40,965,707

  • RCC I

    US$ 59,146,852

Fund Portfolio Manager

Signed grant amount represents the legally committed funds under a signed grant agreement.